# A Trial of AXS-05 in Patients With Major Depressive Disorder

> **NCT04019704** · PHASE3 · COMPLETED · sponsor: **Axsome Therapeutics, Inc.** · enrollment: 327 (actual)

## Conditions studied

- Depression
- Major Depressive Disorder

## Interventions

- **DRUG:** AXS-05
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04019704
- **Lead sponsor:** Axsome Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-20
- **Primary completion:** 2019-11-26
- **Final completion:** 2019-12-05
- **Target enrollment:** 327 (ACTUAL)
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04019704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04019704, "A Trial of AXS-05 in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04019704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*